The levels of TRAF6, a miR-146a target molecule, in PBNs were higher in SLE patients than HCs (Fig. 1d, left, 151.3 ± 16.2% versus 100.0 ± 12.0%, p = 0.038). Here, TRAF6 is linked to systemic lupus erythematosus.